沈阳三九药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
5
NMPA:5
Drug Approvals
Cefoperazone Sodium and Sulbactam Sodium for Injection
- Product Name
- 注射用头孢哌酮钠舒巴坦钠
- Approval Number
- 国药准字H20244618
- Approval Date
- Aug 5, 2024
NMPA
Ceftazidime and Avibactam Sodium for Injection
- Product Name
- 注射用头孢他啶阿维巴坦钠
- Approval Number
- 国药准字H20244625
- Approval Date
- Aug 5, 2024
NMPA
Cefazolin Sodium Pentahydrate
- Product Name
- 五水头孢唑林钠
- Approval Number
- 国药准字H20153069
- Approval Date
- Apr 10, 2015
NMPA
Clinical Trials
No trials found
News
No news found